Literature DB >> 25591777

Hyperketonemia (acetoacetate) upregulates NADPH oxidase 4 and elevates oxidative stress, ICAM-1, and monocyte adhesivity in endothelial cells.

Preeti Kanikarla-Marie1, Sushil K Jain.   

Abstract

BACKGROUND/AIMS: The incidence of developing microvascular dysfunction is significantly higher in type 1 diabetic (T1D) patients. Hyperketonemia (acetoacetate, β-hydroxybutyrate) is frequently found along with hyperglycemia in T1D. Whether hyperketonemia per se contributes to the excess oxidative stress and cellular injury observed in T1D is not known.
METHODS: HUVEC were treated with ketones in the presence or absence of high glucose for 24 h. NOX4 siRNA was used to specifically knockdown NOX4 expression in HUVEC.
RESULTS: Ketones alone or in combination with high glucose treatment cause a significant increase in oxidative stress, ICAM-1, and monocyte adhesivity to HUVEC. Using an antisense approach, we show that ketone induced increases in ROS, ICAM-1 expression, and monocyte adhesion in endothelial cells were prevented in NOX4 knockdown cells.
CONCLUSION: This study reports that elevated levels of ketones upregulate NOX, contributing to increased oxidative stress, ICAM-1 levels, and cellular dysfunction. This provides a novel biochemical mechanism that elucidates the role of hyperketonemia in the excess cellular injury in T1D. New drugs targeting inhibition of NOX seems promising in preventing higher risk of complications associated with T1D.
© 2015 S. Karger AG, Basel.

Entities:  

Mesh:

Substances:

Year:  2015        PMID: 25591777      PMCID: PMC4309197          DOI: 10.1159/000369702

Source DB:  PubMed          Journal:  Cell Physiol Biochem        ISSN: 1015-8987


  54 in total

Review 1.  Autophagy in the brains of young patients with poorly controlled T1DM and fatal diabetic ketoacidosis.

Authors:  William H Hoffman; John J Shacka; Anuska V Andjelkovic
Journal:  Exp Mol Pathol       Date:  2011-11-06       Impact factor: 3.362

Review 2.  Ketone bodies: a review of physiology, pathophysiology and application of monitoring to diabetes.

Authors:  L Laffel
Journal:  Diabetes Metab Res Rev       Date:  1999 Nov-Dec       Impact factor: 4.876

3.  Ketone bodies alter dinitrophenol-induced glucose uptake through AMPK inhibition and oxidative stress generation in adult cardiomyocytes.

Authors:  Amélie Pelletier; Lise Coderre
Journal:  Am J Physiol Endocrinol Metab       Date:  2007-01-16       Impact factor: 4.310

4.  The hospital and home use of a 30-second hand-held blood ketone meter: guidelines for clinical practice.

Authors:  T M Wallace; N M Meston; S G Gardner; D R Matthews
Journal:  Diabet Med       Date:  2001-08       Impact factor: 4.359

5.  Hyperketonemia can increase lipid peroxidation and lower glutathione levels in human erythrocytes in vitro and in type 1 diabetic patients.

Authors:  S K Jain; R McVie
Journal:  Diabetes       Date:  1999-09       Impact factor: 9.461

6.  Distinct effects of ketone bodies on down-regulation of cell surface insulin receptor and insulin receptor substrate-1 phosphorylation in adrenal chromaffin cells.

Authors:  Hiroki Yokoo; Tomokazu Saitoh; Seiji Shiraishi; Toshihiko Yanagita; Takashi Sugano; Shin-Ichi Minami; Hideyuki Kobayashi; Akihiko Wada
Journal:  J Pharmacol Exp Ther       Date:  2003-03       Impact factor: 4.030

Review 7.  Hypertension in severe pediatric diabetic ketoacidosis: case report and review of literature.

Authors:  Hashim Bin Salleh; Quais Mohammad Mujawar
Journal:  Pediatr Emerg Care       Date:  2013-01       Impact factor: 1.454

8.  Long term exposure to fatty acids and ketones inhibits B-cell functions in human pancreatic islets of Langerhans.

Authors:  Y P Zhou; V Grill
Journal:  J Clin Endocrinol Metab       Date:  1995-05       Impact factor: 5.958

9.  Evidence that glucose increases monocyte binding to human aortic endothelial cells.

Authors:  J A Kim; J A Berliner; R D Natarajan; J L Nadler
Journal:  Diabetes       Date:  1994-09       Impact factor: 9.461

10.  Ketosis onset type 2 diabetes had better islet β-cell function and more serious insulin resistance.

Authors:  Hongyun Lu; Fang Hu; Yingjuan Zeng; Lingling Zou; Shunkui Luo; Ying Sun; Hong Liu; Liao Sun
Journal:  J Diabetes Res       Date:  2014-04-13       Impact factor: 4.011

View more
  22 in total

1.  Implications of Altered Ketone Metabolism and Therapeutic Ketosis in Heart Failure.

Authors:  Senthil Selvaraj; Daniel P Kelly; Kenneth B Margulies
Journal:  Circulation       Date:  2020-06-01       Impact factor: 29.690

2.  Hepatocyte-Macrophage Acetoacetate Shuttle Protects against Tissue Fibrosis.

Authors:  Patrycja Puchalska; Shannon E Martin; Xiaojing Huang; Justin E Lengfeld; Bence Daniel; Mark J Graham; Xianlin Han; Laszlo Nagy; Gary J Patti; Peter A Crawford
Journal:  Cell Metab       Date:  2018-11-15       Impact factor: 27.287

Review 3.  Multi-dimensional Roles of Ketone Bodies in Fuel Metabolism, Signaling, and Therapeutics.

Authors:  Patrycja Puchalska; Peter A Crawford
Journal:  Cell Metab       Date:  2017-02-07       Impact factor: 27.287

4.  The contribution of ketone bodies to glycolytic inhibition for the treatment of adult and pediatric glioblastoma.

Authors:  Frederic A Vallejo; Sumedh S Shah; Nicolas de Cordoba; Winston M Walters; Jeffrey Prince; Ziad Khatib; Ricardo J Komotar; Steven Vanni; Regina M Graham
Journal:  J Neurooncol       Date:  2020-02-24       Impact factor: 4.130

5.  Branched chain amino acids and carbohydrate restriction exacerbate ketogenesis and hepatic mitochondrial oxidative dysfunction during NAFLD.

Authors:  Muhammed S Muyyarikkandy; Marc McLeod; Meghan Maguire; Rohit Mahar; Nathan Kattapuram; Christine Zhang; Chaitra Surugihalli; Vaishna Muralidaran; Kruthi Vavilikolanu; Clayton E Mathews; Matthew E Merritt; Nishanth E Sunny
Journal:  FASEB J       Date:  2020-09-12       Impact factor: 5.191

6.  1,25(OH)2D3 inhibits oxidative stress and monocyte adhesion by mediating the upregulation of GCLC and GSH in endothelial cells treated with acetoacetate (ketosis).

Authors:  Preeti Kanikarla-Marie; Sushil K Jain
Journal:  J Steroid Biochem Mol Biol       Date:  2016-03-03       Impact factor: 4.292

Review 7.  Hyperketonemia and ketosis increase the risk of complications in type 1 diabetes.

Authors:  Preeti Kanikarla-Marie; Sushil K Jain
Journal:  Free Radic Biol Med       Date:  2016-03-29       Impact factor: 7.376

8.  Blood metabolomic fingerprint is distinct in healthy coronary and in stenosing or microvascular ischemic heart disease.

Authors:  Martino Deidda; Cristina Piras; Christian Cadeddu Dessalvi; Damiana Congia; Emanuela Locci; Federica Ascedu; Gianfranco De Candia; Mauro Cadeddu; Giorgio Lai; Raimondo Pirisi; Luigi Atzori; Giuseppe Mercuro
Journal:  J Transl Med       Date:  2017-05-23       Impact factor: 5.531

9.  L-cysteine supplementation upregulates glutathione (GSH) and vitamin D binding protein (VDBP) in hepatocytes cultured in high glucose and in vivo in liver, and increases blood levels of GSH, VDBP, and 25-hydroxy-vitamin D in Zucker diabetic fatty rats.

Authors:  Sushil K Jain; Preeti Kanikarla-Marie; Cassandra Warden; David Micinski
Journal:  Mol Nutr Food Res       Date:  2016-04-14       Impact factor: 5.914

Review 10.  Oxidative Stress: Pathogenetic Role in Diabetes Mellitus and Its Complications and Therapeutic Approaches to Correction.

Authors:  M A Darenskaya; L I Kolesnikova; S I Kolesnikov
Journal:  Bull Exp Biol Med       Date:  2021-06-26       Impact factor: 0.804

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.